摘要
目的:评价胺碘酮治疗急性心肌梗死(AMI)室性心律失常的疗效和安全性。方法:观察180例AMI患者采用胺碘酮治疗室性心律失常的疗效和安全性,随访1年。结果:反复发作的持续性室速、室颤患者,首剂3~5mg/kg胺碘酮,10min内静脉注射;再以1.0~1.5mg/min维持,室速均被有效终止。以200mg/d胺碘酮作为长期维持量能有效地控制室性早搏。结论:采用胺碘酮治疗AMI患者室性心律失常效果满意,安全可靠。
Objective: To evaluate the efficacy and safety of amiodarone in the treatment of ventricular arrhythmia in patients with acute myocardial infarction.Methods: 180 patients with ventricular arrhythmia and acute myocardial infarction were treated with amiodarone and followed up 1 year.Results:Intravenous loading dose of 3-5 mg/kg amiodarone was given within 10 minutes,followed by 1.0-1.5 mg/min infusion.The administration of amiodarone was effective in patients with recurrent sustained ventricular tachycardia and fibrillation.Oral maintenance amiodarone dose of 200 mg/d could control ventricular arrythmia.Conclusion:Amiodarone has high efficacy and relative safe for treatment of ventricular arrhythmia in acute myocardial infarction.
出处
《中国医药导报》
CAS
2008年第19期61-62,共2页
China Medical Herald
关键词
胺碘酮
急性心肌梗死
室性心律失常
随访
Amiodarone
Acute myocardial infarction
Ventricular arrythmia
Follow-up